M. Fiege

1.4k total citations
43 papers, 922 citations indexed

About

M. Fiege is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, M. Fiege has authored 43 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in M. Fiege's work include Ion channel regulation and function (28 papers), Cardiac electrophysiology and arrhythmias (12 papers) and Pain Mechanisms and Treatments (3 papers). M. Fiege is often cited by papers focused on Ion channel regulation and function (28 papers), Cardiac electrophysiology and arrhythmias (12 papers) and Pain Mechanisms and Treatments (3 papers). M. Fiege collaborates with scholars based in Germany, United States and Austria. M. Fiege's co-authors include Frank Wappler, Ralf Weißhorn, Mark Ulrich Gerbershagen, T. Krause, Jochen Schulte am Esch, Jens Scholz, Markus Steinfath, Jakob Matschke, Surjit Singh and Martín Schuster and has published in prestigious journals such as Anesthesiology, Anesthesia & Analgesia and British Journal of Anaesthesia.

In The Last Decade

M. Fiege

38 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Fiege Germany 14 489 339 189 105 104 43 922
Zexu Fang United States 18 319 0.7× 155 0.5× 201 1.1× 139 1.3× 86 0.8× 27 1.2k
T. Krause Germany 7 256 0.5× 145 0.4× 119 0.6× 39 0.4× 67 0.6× 19 585
Donald Newgreen United Kingdom 21 408 0.8× 202 0.6× 179 0.9× 99 0.9× 216 2.1× 42 1.4k
Pompiliu Ionescu United States 23 356 0.7× 410 1.2× 297 1.6× 341 3.2× 78 0.8× 56 1.8k
Robert R. Luther United States 16 470 1.0× 260 0.8× 162 0.9× 209 2.0× 366 3.5× 30 1.2k
Paari Dominic United States 19 296 0.6× 654 1.9× 110 0.6× 100 1.0× 94 0.9× 79 1.5k
Ralf Weißhorn Germany 8 281 0.6× 148 0.4× 144 0.8× 35 0.3× 54 0.5× 15 538
Seonghoon Ko South Korea 20 243 0.5× 319 0.9× 145 0.8× 441 4.2× 192 1.8× 57 1.4k
Christoph N. Seubert United States 25 186 0.4× 213 0.6× 121 0.6× 280 2.7× 140 1.3× 74 1.4k
B. E. Waud United States 17 433 0.9× 292 0.9× 133 0.7× 212 2.0× 100 1.0× 35 985

Countries citing papers authored by M. Fiege

Since Specialization
Citations

This map shows the geographic impact of M. Fiege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fiege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fiege more than expected).

Fields of papers citing papers by M. Fiege

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fiege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fiege. The network helps show where M. Fiege may publish in the future.

Co-authorship network of co-authors of M. Fiege

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fiege. A scholar is included among the top collaborators of M. Fiege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fiege. M. Fiege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiege, M., Ralf Weißhorn, Kerstin Kolodzie, Frank Wappler, & Mark Ulrich Gerbershagen. (2011). Effects of Theophylline on Anesthetized Malignant Hyperthermia‐Susceptible Pigs. BioMed Research International. 2011(1). 937479–937479.
2.
Schmidt, Gunter N., M. Fiege, & A. E. Goetz. (2011). Weiterbildung in der Anästhesiologie. Der Anaesthesist. 60(4). 366–374. 1 indexed citations
3.
Schuster, M., et al.. (2007). Kennzahlen der OP-Effizienz. Der Anaesthesist. 56(3). 259–271. 19 indexed citations
4.
Schmidt, Gunter N., et al.. (2007). Die neue Approbationsordnung für Ärzte. Der Anaesthesist. 56(7). 691–701. 1 indexed citations
5.
Schuster, M., et al.. (2007). Auslastung und Wechselzeit als Kennzahlen der OP-Effizienz. Der Anaesthesist. 56(10). 1060–1068. 15 indexed citations
6.
Fiege, M., Frank Wappler, Ralf Weißhorn, et al.. (2005). Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine. European Journal of Anaesthesiology. 22(4). 283–288. 11 indexed citations
7.
Krause, T., Mark Ulrich Gerbershagen, M. Fiege, Ralf Weißhorn, & Frank Wappler. (2004). Dantrolene – A review of its pharmacology, therapeutic use and new developments. Anaesthesia. 59(4). 364–373. 417 indexed citations
8.
Weißhorn, Ralf, Frank Wappler, M. Fiege, et al.. (2004). Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: An experimental approach from a single laboratory. Journal of Clinical Anesthesia. 16(5). 353–357. 1 indexed citations
9.
Gerbershagen, Mark Ulrich, Frank Wappler, M. Fiege, et al.. (2003). Effects of a 5HT 2 receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia. British Journal of Anaesthesia. 91(2). 281–284. 9 indexed citations
10.
Gerbershagen, Mark Ulrich, et al.. (2003). Dantrolen. Der Anaesthesist. 52(3). 238–245. 14 indexed citations
11.
Wappler, Frank, et al.. (2002). In-vitro-Effekte von Kokain an Skelettmuskelpräparaten von Patienten mit Veranlagung zuMaligner Hyperthermie. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 37(3). 138–143. 1 indexed citations
12.
Steinfath, Markus, Peter Seranski, Surjit Singh, et al.. (2002). Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family. Naunyn-Schmiedeberg s Archives of Pharmacology. 366(4). 372–375. 4 indexed citations
13.
Gerbershagen, Mark Ulrich, et al.. (2002). In vitro effects of 4-chloro-3-ethylphenol in skeletal muscle preparations from malignant hyperthermia susceptible and normal swine. European Journal of Anaesthesiology. 19(2). 135–140. 1 indexed citations
14.
Wappler, Frank, M. Fiege, & Jochen Schulte am Esch. (2001). Pathophysiological role of the serotonin system in malignant hyperthermia. British Journal of Anaesthesia. 87(5). 794–798. 32 indexed citations
15.
Gerbershagen, Mark Ulrich, W. Ito, Frank Wappler, M. Fiege, & Jan Schulte Am Esch. (2001). Malignes neuroleptisches Syndrom nach Haloperidolapplikation. Der Anaesthesist. 50(5). 329–332. 2 indexed citations
16.
Felleiter, Peter, M. Fiege, Ruth Fricker, et al.. (2000). A Multicenter Study of 4-Chloro-m-cresol for Diagnosing Malignant Hyperthermia Susceptibility. Anesthesia & Analgesia. 90(1). 200–205. 36 indexed citations
17.
Fiege, M., et al.. (2000). Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients. Journal of Clinical Anesthesia. 12(2). 123–128. 7 indexed citations
18.
Wappler, Frank, et al.. (1999). 4-Chloro-m-cresol is a Trigger of Malignant Hyperthermia in Susceptible Swine. Anesthesiology. 90(6). 1733–1740.. 20 indexed citations
19.
Scholz, Jens, M. Fiege, A. Richter, et al.. (1999). 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients. Naunyn-Schmiedeberg s Archives of Pharmacology. 360(4). 376–381. 4 indexed citations
20.
Wappler, Frank, Jens Scholz, M. Fiege, et al.. (1998). Inzidenz der Disposition zur malignen Hyperthermie bei Patienten mit neuromuskulären Erkrankungen. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 33(6). 373–380. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026